Navigation Links
High Dose Of Vitamin D3 A Boon for Patients Suffering From Heart Failure

Patients with heart failure usually experience inflammation. According to a German clinical trail conducted by Stefanie Schleithoff// from the University of Bonn, it was found that high doses of Vitamin D supplements inhibit the pro-inflammatory molecules and appear to boost the anti-inflammatory function. The results of the study were published in the American Journal of Clinical Nutrition.

The researchers studied the effect of a high-dose vitamin D3 supplement on the heart pumping ability of 123 patients with known chronic heart failure (CHF) for a period of nine months. The participants in one group were given 50 micrograms or 2,000 International Units of vitamin D3 in a form of supplement while a control group took a placebo. Both groups received about 500 milligrams of calcium per day. Researchers also measured the effect of the vitamin D supplement on cytokine levels. Cytokines are powerful pro-inflammatory substances that increase the risk of CHF.

The researchers found that those who received vitamin D supplements had their serum levels of 25-hydroxyvitamin D increased by 26.8 nanograms per millilitre (ng/mL) whereas those in the placebo group had their serum levels of 25-hydroxyvitamin D decreased by 3.6 ng/mL. The 25-hydroxyvitamin D is a storage form of vitamin D in the body. Also the levels of Interleukin 10 (IL-10) was also increased by 43% in the group receiving the vitamin supplements, but showed no change in the placebo group. IL-10 is an anti-inflammatory compound.

When the heart function was also measured in all participants as marked by left ventricular ejection fraction (LVEF) there was no difference between both the groups. In conclusion the researchers said that a daily supplement of 50 micrograms vitamin D for nine months is able to increase serum concentrations of the anti-inflammatory cytokine IL-10 and also helps to prevent an increase in serum concentrations of the pro-inflammatory cytokine TNF-alpha in CHF pa
'"/>




Page: 1 2

Related medicine news :

1. Vitamin B12 can help in detecting cancers
2. Vitamins-The answer to Heart Disease?
3. Vitamin E, the latest warrior against diabetes
4. Vitamin Shields Brittle Bones
5. B Vitamin protects and lowers toxicity of Arthritis Drug
6. B Vitamin Supplementatoin Saves Money and Lives
7. Eat Vitamin C and stay young
8. Vitamin C for the heart
9. Vitamin B for Hepatitis
10. Vitamins reduce pre-eclampsia
11. Vitamin E useful for Alzheimers
Post Your Comments:
(Date:7/3/2009)... July 3 Bertalan Mesko, medical bl...e e-guide for medical professionals focusing on ...dical conferences are expensive and patients are a...is eGuide helps doctors enter a virtual realm and ...ee as Second Life provides opportunities for case ...
(Date:7/3/2009)... Republicans on the Sen...health care reform legislation that would eliminat... many women could lose coverage for abortion servi...s. Plus, millions of uninsured women will still la... promised a better quality of life. , , If thes...
(Date:7/3/2009)... ReverseAges.com launches new content to includ...atigue, and how to best deal with these health iss...EB) July 3, 2009 -- ReverseAges.com has recently l... the dangers of common health issues such as high ... variety of factors, and the new content on Revers...
(Date:7/2/2009)...ore,s Bioprocessing Technology Institute (BTI) hav...apoptosis inhibitory molecule" (FAIM), protects bo...ammed cell death. , Their research is published...ation . , The scientists, Jianxin Huo, Ph.D., an...cess may possibly be manipulated for clinical appl...
Breaking Medicine News(10 mins):Health News:Gene's novel role may provide key to treating liver and neurodegenerative diseases 2
...d a study, the first of its kind to link cholester...rformed on mice, yet scientists say the findings m...ype 2 diabetes is still unknown. There are varied ...he features of this disease is the reduction in pr...
..., MD, PhD, published the first results showing tha.../ could be an effective gene therapy technique. Si...ely shut down the viruses that cause hepatitis and...ene therapy trials now under way - two in macular ...
...Psychological Association (APA) has found evidence...rls and young// women in advertising and media is ...nt. To complete the report, the APA Task Force on...blished research on the content and effects of vir...
...ght could have an adverse effect on your performan...ow important the evening slumber is for students. ...School Of Medicine and other researchers examined ...roved questionnaires, filled out by students atten...
Other Medicine News:Health News:Cholesterol and Insulin Secretion -bound by a Gene 2Health News:RNAi Shows Promise in Gene Therapy 2Health News:Sexualization Linked to Mental Health Problems in Girls and Women 2Health News:Sleep Disturbances Could Affect Performances in School 2
(Date:6/30/2009)...., June 30 Cephalon, Inc...bmitted a supplemental New Drug Application (sNDA)...questing approval of NUVIGIL(R) (armodafinil) Tabl...ess in patients with excessive sleepiness associat...travel. Jet lag disorder is an acute condition th...
(Date:6/29/2009)...ajor abdominal surgery patients achieved primary a..., June 29 AcelRx Pharmaceuticals, ...ond Phase 2 clinical study evaluating the safety a...for the management of acute post-operative pain in...alization. Compared to placebo, patients receiving...
(Date:6/28/2009)...NHAM, England and TOKYO, June 29 ,... Companies , Sosei Group Corporation ("Sose...c ("Vectura"; LSE: VEC) announce the commencement ...VA237, a once-daily, long-acting muscarinic,antag...ive pulmonary disease,(COPD). NVA237 is a dry pow...
(Date:6/26/2009)...pinion Recommends Approval of New Anti-TNF Therapy...TM) Autoinjector , , HORSHAM, Pa. and KENILWORT...r Ortho Biotech Inc. and Schering-Plough Corporati...ee for Medicinal Products for Human Use (CHMP) of ...itive opinion recommending the approval of SIMPONI...
Breaking Medicine Technology:Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 3Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 4AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10Vermont Surgeon Implants First Accommodating Crystalens in Russia 9146 1Vermont Surgeon Implants First Accommodating Crystalens in Russia 9146 2PLC Systems Updates Common Stock Listing Status 29620 1PLC Systems Updates Common Stock Listing Status 29620 2Soft Contact Lenses Do Not Lead to Myopic Creep in Children Study Shows 3438 1Soft Contact Lenses Do Not Lead to Myopic Creep in Children Study Shows 3438 2Soft Contact Lenses Do Not Lead to Myopic Creep in Children Study Shows 3438 3Advanced Imaging Technologies to Limit Breast and GI Biopsy Procedures 29614 1Advanced Imaging Technologies to Limit Breast and GI Biopsy Procedures 29614 2
...Investigational cancer drug Pertuzumab shows promi...ed with Herceptin Phase III,development initiated,...esults from,Roche,s trial of the exciting new canc...or, show substantial anti-tumour activity in,patie...when,combined with Herceptin. The study showed tha...
...- First Agent Ever to Demonstrate Significant Surv...2007 /PRNewswire-FirstCall/ -- Bayer,HealthCare Ph...today announced that Nexavar(R) (sorafenib) tablet...nts with hepatocellular carcinoma,(HCC), or primar...(HR=0.69; p-value=0.0006). Results were presented ...
Other Medicine Technology:Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 2Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 3Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 4Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7
Double round silicone drain with trocar, 49 in. long, with 12.25 in. (30.5 cm) hole pattern
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe.
Used for percutaneous placement of laparoscopic surgical instruments. Check-Flo® valve provides a secure seal around the instruments to be introduced. Supplied sterile in peel-open packages. Inte
Used for cholangiography and bile stone removal using fluoroscopy. Dual lumen catheter design allows concomitant fluoroscopic biliary imaging and wire basket placement for stone extraction. Supplied
Medicine Products: